MicroRNA expression profiles in peri-miniscrew implant crevicular fluid in orthodontics: a pilot study

Wendan He1,2, Yanru Yang3, Longgan Cai2

  • 1Capital Medical University School of Stomatology, Beijing, 100006, China.

BMC Oral Health
|December 19, 2021
PubMed
Abstract

Insights

This study identified distinct microRNA (miRNA) profiles in peri-miniscrew implant crevicular fluid (PMICF) from patients with peri-implantitis. Specific miRNAs show potential as diagnostic markers for this condition.

Area of Science:

  • Oral biology
  • Molecular biology
  • Biochemistry

Background:

  • MicroRNA (miRNA) expression in peri-miniscrew implant crevicular fluid (PMICF) is not well understood in orthodontic patients.
  • Peri-implantitis (PMSII) is a significant complication of orthodontic mini-implants.

Purpose of the Study:

  • To systematically evaluate miRNA expression patterns in PMICF of orthodontic patients.
  • To identify potential diagnostic biomarkers for peri-implantitis.

Main Methods:

  • Next-generation sequencing (NGS) to profile miRNAs in PMICF and gingival crevicular fluid (GCF).
  • Quantitative real-time PCR (qRT-PCR) for differential miRNA expression validation.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for target gene enrichment.

Main Results:

  • Significant differences in miRNA expression were observed between healthy donors, peri-implantitis patients, and periodontitis patients.
  • NGS revealed numerous upregulated and downregulated miRNAs in PMSII patients compared to healthy controls.
  • qRT-PCR validated elevated levels of miR-1245b-3p and miR-4291 in PMSII, and miR-1825 in periodontitis patients. Enrichment analysis highlighted the PI3K-AKT signaling pathway.

Conclusions:

  • Distinct miRNA profiles exist in normal and orthodontic PMICF/GCF, suggesting a basis for understanding PMSII molecular mechanisms.
  • miR-4291, miR-1245b-3p, and miR-1825 are potential diagnostic markers and therapeutic targets for peri-implantitis.